The studies on the Ophthalmic drug development
碩士 === 國立陽明大學 === 生物藥學研究所 === 94 === Age-related macular degeneration (AMD) causes gradual loss of central vision by damaging the retinal pigment epithelial (RPE) cells. In the present day there haven’t found the correct target for drug development in AMD. By far the therapy can only treat the secon...
Main Authors: | shih-hsien Wong, 翁詩嫻 |
---|---|
Other Authors: | Rong-Tsun Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/12659230736215028238 |
Similar Items
-
A platform study of ophthalmic drug development
by: Kai Lee, et al.
Published: (2008) -
Study on the Platform of Drug Development of Ophthalmic Disease
by: Tzu-Ning Liu, et al.
Published: (2013) -
Ophthalmic Drug Delivery
Published: (2023) -
Study on the Platform for Ophthalmic Drug Development and Active Ingredients Production
by: Hsing-Yu Pan, et al.
Published: (2014) -
Development of an In Vitro Blink Model for Ophthalmic Drug Delivery
by: Chau-Minh Phan, et al.
Published: (2021-02-01)